tiprankstipranks
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
US Market

Syndax Pharmaceuticals (SNDX) Income Statement

Compare
657 Followers

Syndax Pharmaceuticals Income Statement

Last quarter (Q3 2024), Syndax Pharmaceuticals's total revenue was $12.50M, an increase of Infinity% from the same quarter last year. In Q3, Syndax Pharmaceuticals's net income was $-84.13M. See Syndax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 139.71M$ 1.52M$ 1.52M
Gross Profit
$ -12.00K$ -454.00K$ 139.25M$ 1.52M$ 1.52M
Operating Expenses
$ 229.95M$ 151.76M$ 113.49M$ 72.94M$ 59.06M
Depreciation and Amortization
$ 12.00K$ 454.00K$ 456.00K$ 515.00K$ 451.00K
EBITDA
$ -229.94M$ -151.76M$ 27.28M$ -70.29M$ -55.60M
Operating Income
$ -229.95M$ -151.76M$ 26.22M$ -71.42M$ -57.54M
Other Income/Expenses
$ 20.59M$ 2.42M$ -1.29M$ -1.74M$ 1.49M
Pretax Income
$ -209.36M$ -149.34M$ 24.93M$ -73.16M$ -56.05M
Net Income
$ -209.36M$ -143.75M$ 24.93M$ -73.07M$ -55.95M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.98$ -2.37$ 0.48$ -1.77$ -1.84
Diluted EPS
$ -2.98$ -2.37$ 0.46$ -1.77$ -1.84
Weighted Average Shares Outstanding
70.26M 60.76M 52.06M 41.31M 30.49M
Weighted Average Shares Outstanding (Diluted)
70.37M 60.76M 53.62M 41.31M 30.49M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis